Piper Sandler Downgrades Biogen (BRSE:BIIB)

Fintel reports that on January 2, 2025, Piper Sandler downgraded their outlook for Biogen (BRSE:BIIB) from Overweight to Neutral.

What is the Fund Sentiment?

There are 1,768 funds or institutions reporting positions in Biogen. This is an decrease of 39 owner(s) or 2.16% in the last quarter. Average portfolio weight of all funds dedicated to BIIB is 0.17%, an increase of 31.42%. Total shares owned by institutions increased in the last three months by 2.44% to 146,574K shares.

What are Other Shareholders Doing?

CH:BIIB / Biogen Inc. Shares Held by Institutions

Primecap Management holds 16,315K shares representing 11.20% ownership of the company. In its prior filing, the firm reported owning 16,338K shares , representing a decrease of 0.14%. The firm decreased its portfolio allocation in BIIB by 15.20% over the last quarter.

VPMCX - Vanguard PRIMECAP Fund Investor Shares holds 9,180K shares representing 6.30% ownership of the company. In its prior filing, the firm reported owning 9,155K shares , representing an increase of 0.27%. The firm decreased its portfolio allocation in BIIB by 15.67% over the last quarter.

Jpmorgan Chase holds 5,257K shares representing 3.61% ownership of the company. In its prior filing, the firm reported owning 4,715K shares , representing an increase of 10.32%. The firm increased its portfolio allocation in BIIB by 871.73% over the last quarter.

Wellington Management Group Llp holds 5,131K shares representing 3.52% ownership of the company. In its prior filing, the firm reported owning 5,166K shares , representing a decrease of 0.69%. The firm decreased its portfolio allocation in BIIB by 88.57% over the last quarter.

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 4,621K shares representing 3.17% ownership of the company. In its prior filing, the firm reported owning 4,614K shares , representing an increase of 0.17%. The firm decreased its portfolio allocation in BIIB by 21.33% over the last quarter.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.